Solid Biosciences Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 56.9% | 56.9% | — |
| FY2017 | 88.0% | 88.0% | -68.4% |
| FY2018 | -59.8% | -59.8% | -53.6% |
| FY2019 | -146.4% | -146.4% | -113.3% |
| FY2020 | -66.8% | -66.8% | -51.6% |
| FY2021 | -34.7% | -34.7% | -31.1% |
| FY2022 | -40.6% | -40.6% | -33.0% |
| FY2023 | -75.9% | -75.9% | -58.2% |
| FY2024 | -90.9% | -90.9% | -66.1% |
| FY2025 | -96.8% | -96.8% | -75.0% |